Connect with us

Health

Counterfeit/Falsified Drug Alert: Ozempic

Published

on

PRESS RELEASE

FROM THE MINISTRY OF HEALTH AND HUMAN SERVICES

 

Cockburn Town, Turks and Caicos Islands, 2nd May 2025: In response to a U.S. Food and Drug Administration (FDA) alert relating to the identification of hundreds of counterfeit/falsified Ozempic(semaglutide) 1mg injection in the U.S. drug supply chain, the Ministry of Health and Human Services (MoHHS) wishes to alert all pharmacies, other healthcare providers and consumers to be vigilant when procuring this product from online or instore vendors who source this medicine from the US supply chain.

According to the FDA alert, Novo Nordisk – the genuine manufacturer – issued the initial notification revealing that the counterfeit Ozempic was distributed outside their authorised supply chain in the U.S. Medical products are considered counterfeit/falsified when their identity, composition or source are deliberately or fraudulently misrepresented. Ozempic is used to treat hyperglycaemia (high blood sugar) in type 2 diabetes mellitus in adults, adolescents and children over 12 years of age. It is also used to treat obesity.

Importantly, Novo Nordisk revealed that the counterfeit product’s label displays the following:

  • lot number PAR0362 (which is authentic) and
  • an illegitimate serial number starting with the first eight digits 51746517.

Novo Nordisk has indicated that only when both the lot number and the first eight digits 51746517 are used together should the product be considered counterfeit.  Neither Novo Nordisk nor the FDA can confirm the contents or quality of the counterfeit product, which may present a safety risk for patients who use the counterfeit product. Therefore, if used, these counterfeit products may result in the ineffective treatment of patients due to incorrect dosage, contamination with harmful substances, or use of unknown or substituted ingredients. This may pose serious risks – that could be life-threatening – to health because they are administered by subcutaneous injection. Notably, the FDA is aware of six adverse event reports linked with this lot, however, none of them appear to be associated with the counterfeit product.

The Minister of Health and Human Services – Hon. Kyle R. Knowles, and the MoHHS’ top priority is to ensure public health safety and so in light of this update are imploring all wholesalers, retail pharmacies and other healthcare professionals to:

  1. Examine all Ozempic products received from within the US supply chain.
  2. Administer, dispense, distributeor sell the counterfeit Ozempic labelled with lot number PAR0362 and serial number starting with the first eight digits 51746517.
  3. Quarantine all remaining stock(s) of the counterfeit pens for possible disposal by the Environmental Health Department (contact: 338-2142).
  4. Notify your overseas suppliers for any additional information.

Patients/consumers are encouraged:

  1. Not to useany counterfeit Ozempic 1mg injection labelled with lot number PAR0362 and serial number starting with the first eight digits 51746517.
  2. To contact their physicians and/or pharmacist if they have any questions or concerns before using any Ozempic 1mg injection.
  3. To purchase Ozempic 1mg injection only from authorised pharmacies and not online stores.
  4. To report any suspected side effects associated with Ozempic 1mg injection via the MoHHS Adverse Drug Reaction Form found at https://gov.tc/docs/ADR.pdf.

For further information, please contact André Morgan, National Pharmacist at: (649)338-3072 or amorgan@gov.tc.

Continue Reading

Bahamas News

More Bahamians Accessing HIV, STI Care Through NHI

Published

on

NASSAU, Bahamas — More Bahamians are accessing HIV and sexually transmitted infection-related healthcare through National Health Insurance, a trend the NHI Authority says should be viewed positively.

NHIA stressed in an August 6 statement that its 2025 figures measure healthcare utilisation, not newly diagnosed infections. They include beneficiaries screened, treated, monitored or receiving follow-up care, including people diagnosed previously.

“Increased utilisation of these services should be viewed as a positive development,” NHIA said.

The Authority pointed to “greater enrolment and use of NHI, improved access to screening and testing, continued treatment and monitoring of existing conditions, and increased willingness to seek medical care.”

The development comes amid a mixed three-year HIV picture. New diagnoses rose from 130 in 2023 to 156 in 2024, before declining to 142 in 2025.

NHIA said increased utilisation demonstrates that more beneficiaries are accessing needed healthcare and actively managing their health, reinforcing the importance of screening, early diagnosis and continued treatment.

Continue Reading

Health

47,459 MEASLES CASES, 44 DEATHS ACROSS AMERICAS  

Published

on

WASHINGTON, D.C. — The Americas has recorded 47,459 confirmed measles cases and 44 deaths in 2026, the region’s highest case count in 22 years, prompting the Pan American Health Organization (PAHO) to urge stronger vaccination, surveillance and rapid outbreak response.

As of July 18, cases were already more than triple the 15,011 recorded during all of 2025. Guatemala, Mexico, the United States and Peru account for 95% of confirmed cases. Guatemala leads with 30,371 cases and 26 deaths, followed by Mexico with 12,255 cases and 17 deaths.

PAHO classifies the regional public health risk as very high, citing active outbreaks, immunity gaps, international travel and populations with inadequate vaccination coverage.

The organization says prevention starts with vaccination. Countries are being urged to achieve and maintain at least 95% coverage with two doses of measles-containing vaccine, particularly protecting children and under-vaccinated communities.

Measles spreads through the air when an infected person breathes, coughs or sneezes. Symptoms can include fever, cough, runny nose, red eyes and a rash.

PAHO is urging health authorities to detect suspected cases early and respond rapidly to stop transmission. Unvaccinated and under-vaccinated people, young children and communities with limited healthcare access face increased risk of severe illness and death.

Continue Reading

Caribbean News

From Pathways to Investment: Tackling the US $6 Billion Food Challenge for the Caribbean

Published

on

By Kenroy Roach

The Caribbean’s food systems challenge is fast evolving into a broader development challenge.

Despite decades of policy attention and investment, the region remains one of the most food import-dependent in the world, spending over US$6 billion annually. At the same time, countries continue to grapple with food insecurity, high rates of diet-related non-communicable diseases, climate vulnerability, and exposure to external shocks that can disrupt supply chains and drive up food prices almost overnight.

For Small Island Developing States (SIDS), food security has shifted from an agriculture focus alone, it’s about economic resilience, health, climate resilience and sustainable growth.

Recognizing this reality, Caribbean governments have elevated food systems transformation as a regional priority through the CARICOM 25 x 25 Plus Five Agenda, which seeks to reduce food import dependence while strengthening domestic production, regional trade, and resilience. Across Barbados and the Eastern Caribbean, governments have also developed National Food Systems Pathways that identify the investments, partnerships, and policy reforms needed to transform food systems and accelerate progress toward the Sustainable Development Goals (SDGs).

Yet one challenge has remained persistent: financing.

In the face of high levels of public debt and limited fiscal space, while public investment remains critical, Caribbean governments simply cannot shoulder the financing burden alone. Transforming food systems at scale requires mobilizing far greater private capital, alongside development finance and public resources.

This was the rationale behind the recent convened in Barbados.

The Forum brought together governments, investors, international financial institutions, private sector leaders, regional organizations, and the United Nations around a simple proposition: food systems should be viewed not only as a development priority, but also as an investable asset class.

A distinguishing feature of the innovative gathering was its focus on attracting private investment—particularly private equity, impact investment, and blended finance solutions capable of supporting businesses and infrastructure across food value chains. By helping enterprises access growth capital and connecting investors with scalable opportunities, the initiative sought to unlock financing that complements public investment rather than adding to already constrained public balance sheets.

A key outcome was the launch of a regional Deal Book comprising approximately US$320 million in investment opportunities across seven countries, spanning agriculture, fisheries, agro-processing, logistics, and strategic food systems infrastructure. The Deal Book created a practical bridge between capital seeking opportunities and opportunities seeking capital, while enabling direct engagement between governments, enterprises, and investors.

The results were encouraging.

Across four sector-focused deal rooms, participants explored investment-ready and near-investment-ready opportunities and discussed blended finance private equity, risk-sharing, and partnerships to advance projects toward implementation.

The Forum highlighted a shift in perspective: food systems are now seen as strategic drivers of economic diversification, resilience, competitiveness, and growth. Investments across production, processing, logistics, and distribution can strengthen regional supply chains, create new businesses, generate jobs, and reduce vulnerability to external shocks.

For the United Nations, this experience reinforced an important lesson.

Transforming food systems requires more than the technical expertise of individual agencies. It requires integrated solutions that connect agriculture, nutrition, health, climate resilience, trade, private sector development, and financing.

This is where the Resident Coordinator System plays a critical role.

Across Barbados and the Eastern Caribbean, the Resident Coordinator Office has united UN system capabilities around a common food systems agenda. Working with FAO, WFP, the UN Food Systems Coordination Hub, and other partners, the RCO has helped align policy support, technical expertise, partnerships, and financing with nationally identified priorities.

The Forum demonstrated this integrated approach by convening governments, investors, development finance institutions, private sector actors, and UN agencies around a common objective. It showcased the UN’s comparative advantage as a trusted broker capable of connecting development priorities with investment opportunities.

The Forum’s success will be measured not by dialogue generated, but by investments mobilized, businesses expanded, and progress made toward resilient, competitive Caribbean food systems across the Caribbean.

Its most important outcome may therefore be what comes next.

The work starts now.

Kenroy Roach is Head of the UN Resident Coordinator Office for Barbados and the Eastern Caribbean

Continue Reading

FIND US ON FACEBOOK

TRENDING